Search

Your search keyword '"Mahoney, Douglas W."' showing total 843 results
Start Over Author "Mahoney, Douglas W."
843 results on '"Mahoney, Douglas W."'

1. Algorithm Training and Testing for a Nonendoscopic Barrett’s Esophagus Detection Test in Prospective Multicenter Cohorts

Author

Iyer, Prasad G., Slettedahl, Seth W., Mahoney, Douglas W., Giakoumopoulos, Maria, Olson, Marilyn C., Krockenberger, Martin, Taylor, William R., Foote, Patrick, Berger, Calise, Leggett, Cadman, Wu, Tsung-Teh, Antpack, Eduardo, Falk, Gary W., Ginsberg, Gregory G., Abrams, Julian A., Lightdale, Charles J., Ramirez, Francisco, Kahn, Allon, Wolfsen, Herbert, Konda, Vani, Trindade, Arvind J., and Kisiel, John B.

Published
2024
Full Text
View/download PDF

2. Neoplasia Diagnosis After Multi-target Stool DNA Is Enhanced Among Lowest Baseline Detectors

Author

Ebner, Derek W., Burger, Kelli N., Mahoney, Douglas W., Broderick, Brendan T., Eckmann, Jason D., Devens, Mary E., Lowrie, Kari L., League, John B., Bering, Jamie, Kahn, Allon, Rodriguez, Eduardo A., Prichard, David O., Wallace, Michael B., Kane, Sunanda V., Leighton, Jonathan A., Buttar, Navtej S., Rutten, Lila J. Finney, Gurudu, Suryakanth R., and Kisiel, John B.

Published
2023
Full Text
View/download PDF

3. Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease

Author

Bartemes, Kathleen R., Gochanour, Benjamin R., Routman, David M., Ma, Daniel J., Doering, Karen A., Burger, Kelli N., Foote, Patrick H., Taylor, William R., Mahoney, Douglas W., Berger, Calise K., Cao, Xiaoming, Then, Sara S., Haller, Travis J., Larish, Alyssa M., Moore, Eric J., Garcia, Joaquin J., Graham, Rondell P., Bakkum-Gamez, Jamie N., Kisiel, John B., and Van Abel, Kathryn M.

Published
2023
Full Text
View/download PDF

5. Detection of endometrial cancer using tampon-based collection and methylated DNA markers

Author

Bakkum-Gamez, Jamie N., Sherman, Mark E., Slettedahl, Seth W., Mahoney, Douglas W., Lemens, Maureen A., Laughlin-Tommaso, Shannon K., Hopkins, Matthew R., VanOosten, Ann, Shridhar, Viji, Staub, Julie K., Cao, Xiaoming, Foote, Patrick H., Clarke, Megan A., Burger, Kelli N., Berger, Calise K., O'Connell, Maria C., Doering, Karen A., Podratz, Karl C., DeStephano, Christopher C., Schoolmeester, J. Kenneth, Kerr, Sarah E., Wentzensen, Nicolas, Taylor, William R., and Kisiel, John B.

Published
2023
Full Text
View/download PDF

6. Plasma Methylated DNA Markers for Melanoma Surveillance

Author

Berger, Calise K., Taylor, William R., Mahoney, Douglas W., Burger, Kelli N., Doering, Karen A., Gonser, Anna M., Cao, Xiaoming, Heilberger, Justin, Gysbers, Brianna J., Foote, Patrick H., Kottschade, Lisa A., Markovic, Svetomir N., Lehman, Julia S., Katerov, Viatcheslav E., Allawi, Hatim T., Kisiel, John B., and Meves, Alexander

Published
2023
Full Text
View/download PDF

8. An investigation of plasma cell-free RNA for the detection of colorectal cancer: From transcriptome marker selection to targeted validation.

Author

Northrop-Albrecht, Emmalee J., Wu, Chung Wah, Berger, Calise K., Taylor, William R., Foote, Patrick H., Doering, Karen A., Gonser, Anna M., Bhagwate, Aditya, Sun, Zhifu, Mahoney, Douglas W., Burger, Kelli N., Boardman, Lisa A., and Kisiel, John B.

Subjects
COLORECTAL cancer, RNA sequencing, INDEPENDENT sets, EARLY detection of cancer, DATA analysis
Abstract

Regular screening for colorectal cancer (CRC) is critical for early detection and long-term survival. Despite the current screening options available and advancements in therapies there will be around 53,000 CRC related deaths this year. There is great interest in non-invasive alternatives such as plasma cell-free RNA (cfRNA) for diagnostic, prognostic, and predictive applications. In the current study, our aim was to identify and validate potential cfRNA candidates to improve early CRC diagnosis. In phase 1 (n = 49; 25 controls, 24 cancers), discovery total RNA sequencing was performed. Select exons underwent validation in phase 2 (n = 73; 35 controls, 29 cancers, 9 adenomas) using targeted capture sequencing (n = 10,371 probes). In phase 3 (n = 57; 30 controls, 27 cancers), RT-qPCR was performed on previously identified candidates (n = 99). There were 895 exons that were differentially expressed (325 upregulated, 570 downregulated) among cancers versus controls. In phases 2 and 3, fewer markers were validated than expected in independent sets of patients, most of which were from previously published literature (FGA, FGB, GPR107, CDH3, and RP23AP7). In summary, we optimized laboratory processes and data analysis strategies which can serve as methodological framework for future plasma RNA studies beyond just the scope of CRC detection. Additionally, further exploration is needed in order to determine if the few cfRNA candidates identified in this study have clinical utility for early CRC detection. Over time, advancements in technologies, data analysis, and RNA preservation methods at time of collection may improve the biological and technical reproducibility of cfRNA biomarkers and enhance the feasibility of RNA-based liquid biopsies. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Methylated DNA Markers in Voided Urine for the Identification of Clinically Significant Prostate Cancer.

Author

Shah, Paras, Taylor, William R., Negaard, Brianna J., Gochanour, Benjamin R., Mahoney, Douglas W., Then, Sara S., Devens, Mary E., Foote, Patrick H., Doering, Karen A., Burger, Kelli N., Nikolai, Brandon, Kaiser, Michael W., Allawi, Hatim T., Cheville, John C., Kisiel, John B., and Gettman, Matthew T.

Subjects
PROSTATE cancer patients, GENETIC markers, PROSTATE-specific antigen, PROSTATE biopsy, DNA methylation
Abstract

Introduction: Non-invasive assays are needed to better discriminate patients with prostate cancer (PCa) to avoid over-treatment of indolent disease. We analyzed 14 methylated DNA markers (MDMs) from urine samples of patients with biopsy-proven PCa relative to healthy controls and further studied discrimination of clinically significant PCa (csPCa) from healthy controls and Gleason 6 cancers. Methods: To evaluate the panel, urine from 24 healthy male volunteers with no clinical suspicion for PCa and 24 men with biopsy-confirmed disease across all Gleason scores was collected. Blinded to clinical status, DNA from the supernatant was analyzed for methylation signal within specific DNA sequences across 14 genes (HES5, ZNF655, ITPRIPL1, MAX.chr3.6187, SLCO3A1, CHST11, SERPINB9, WNT3A, KCNB2, GAS6, AKR1B1, MAX.chr3.8028, GRASP, ST6GALNAC2) by target enrichment long-probe quantitative-amplified signal assays. Results: Utilizing an overall specificity cut-off of 100% for discriminating normal controls from PCa cases across the MDM panel resulted in 71% sensitivity (95% CI: 49–87%) for PCa detection (4/7 Gleason 6, 8/12 Gleason 7, 5/5 Gleason 8+) and 76% (50–92%) for csPCa (Gleason ≥ 7). At 100% specificity for controls and Gleason 6 patients combined, MDM panel sensitivity was 59% (33–81%) for csPCa (5/12 Gleason 7, 5/5 Gleason 8+). Conclusions: MDMs assayed in urine offer high sensitivity and specificity for detection of clinically significant prostate cancer. Prospective evaluation is necessary to estimate discrimination of patients as first-line screening and as an adjunct to prostate-specific antigen (PSA) testing. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

12. Figure S2 from Next-generation Multi-target Stool DNA Panel Accurately Detects Colorectal Cancer and Advanced Precancerous Lesions

Author

Gagrat, Zubin D., primary, Krockenberger, Martin, primary, Bhattacharya, Abhik, primary, Gagrat, Bridget Z., primary, Leduc, Christine M., primary, Matter, Michael B., primary, Fourrier, Keith D., primary, Mahoney, Douglas W., primary, Edwards V, David K., primary, Lidgard, Graham P., primary, Limburg, Paul J., primary, Johnson, Scott C., primary, Domanico, Michael J., primary, and Kisiel, John B., primary

Published
2024
Full Text
View/download PDF

13. Table S1 from Next-generation Multi-target Stool DNA Panel Accurately Detects Colorectal Cancer and Advanced Precancerous Lesions

Author

Gagrat, Zubin D., primary, Krockenberger, Martin, primary, Bhattacharya, Abhik, primary, Gagrat, Bridget Z., primary, Leduc, Christine M., primary, Matter, Michael B., primary, Fourrier, Keith D., primary, Mahoney, Douglas W., primary, Edwards V, David K., primary, Lidgard, Graham P., primary, Limburg, Paul J., primary, Johnson, Scott C., primary, Domanico, Michael J., primary, and Kisiel, John B., primary

Published
2024
Full Text
View/download PDF

14. Data from Next-generation Multi-target Stool DNA Panel Accurately Detects Colorectal Cancer and Advanced Precancerous Lesions

Author

Gagrat, Zubin D., primary, Krockenberger, Martin, primary, Bhattacharya, Abhik, primary, Gagrat, Bridget Z., primary, Leduc, Christine M., primary, Matter, Michael B., primary, Fourrier, Keith D., primary, Mahoney, Douglas W., primary, Edwards V, David K., primary, Lidgard, Graham P., primary, Limburg, Paul J., primary, Johnson, Scott C., primary, Domanico, Michael J., primary, and Kisiel, John B., primary

Published
2024
Full Text
View/download PDF

15. Algorithm Training and Testing for a Non-Endoscopic Barrett’s Esophagus Detection Test in Prospective Multicenter Cohorts

Author

Iyer, Prasad G., primary, Slettedahl, Seth W., additional, Mahoney, Douglas W., additional, Giakoumopoulos, Maria, additional, Olson, Marilyn C., additional, Krockenberger, Martin, additional, Taylor, William R., additional, Foote, Patrick, additional, Berger, Calise, additional, Leggett, Cadman, additional, Wu, T.T., additional, Antpack, Eduardo, additional, Falk, Gary W., additional, Ginsberg, Gregory G., additional, Abrams, Julian A., additional, Lightdale, Charles J., additional, Ramirez, Francisco, additional, Kahn, Allon, additional, Wolfsen, Herbert, additional, Konda, Vani, additional, Trindade, Arvind J., additional, and Kisiel, John B., additional

Published
2024
Full Text
View/download PDF

17. Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls

Author

Majumder, Shounak, Raimondo, Massimo, Taylor, William R., Yab, Tracy C., Berger, Calise K., Dukek, Brian A., Cao, Xiaoming, Foote, Patrick H., Wu, Chung Wah, Devens, Mary E., Mahoney, Douglas W., Smyrk, Thomas C., Pannala, Rahul, Chari, Suresh T., Vege, Santhi Swaroop, Topazian, Mark D., Petersen, Bret T., Levy, Michael J., Rajan, Elizabeth, Gleeson, Ferga C., Abu Dayyeh, Barham, Nguyen, Cuong C., Faigel, Douglas O., Woodward, Timothy A., Wallace, Michael B., Petersen, Gloria, Allawi, Hatim T., Lidgard, Graham P., Kisiel, John B., and Ahlquist, David A.

Published
2020
Full Text
View/download PDF

18. Next-generation Multi-target Stool DNA Panel Accurately Detects Colorectal Cancer and Advanced Precancerous Lesions

Author

Gagrat, Zubin D., primary, Krockenberger, Martin, additional, Bhattacharya, Abhik, additional, Gagrat, Bridget Z., additional, Leduc, Christine M., additional, Matter, Michael B., additional, Fourrier, Keith D., additional, Mahoney, Douglas W., additional, Edwards V, David K., additional, Lidgard, Graham P., additional, Limburg, Paul J., additional, Johnson, Scott C., additional, Domanico, Michael J., additional, and Kisiel, John B., additional

Published
2024
Full Text
View/download PDF

19. Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer Therapies

Author

Zhu, Mojun, primary, Taylor, William R., additional, Mahoney, Douglas W., additional, Then, Sara S., additional, Berger, Calise K., additional, Burger, Kelli N., additional, Gonser, Anna M., additional, Doering, Karen A., additional, Xie, Hao, additional, Foote, Patrick H., additional, Kaiser, Michael W., additional, Allawi, Hatim T., additional, Hubbard, Joleen M., additional, and Kisiel, John B., additional

Published
2023
Full Text
View/download PDF

20. Supplemental Figure 1 from Methylated DNA Markers for Sporadic Colorectal and Endometrial Cancer Are Strongly Associated with Lynch Syndrome Cancers

Author

Bramblet, Rachel M., primary, Bakkum-Gamez, Jamie N., primary, Slettedahl, Seth W., primary, Foote, Patrick H., primary, Taylor, William R., primary, Berger, Calise K., primary, Gysbers, Brianna J., primary, Arndt, Jacquelyn, primary, Chen, Longwen, primary, Doering, Karen A., primary, Burger, Kelli N., primary, Mahoney, Douglas W., primary, Sherman, Mark E., primary, Kisiel, John B., primary, and Samadder, N. Jewel, primary

Published
2023
Full Text
View/download PDF

21. Data from Methylated DNA Markers for Sporadic Colorectal and Endometrial Cancer Are Strongly Associated with Lynch Syndrome Cancers

Author

Bramblet, Rachel M., primary, Bakkum-Gamez, Jamie N., primary, Slettedahl, Seth W., primary, Foote, Patrick H., primary, Taylor, William R., primary, Berger, Calise K., primary, Gysbers, Brianna J., primary, Arndt, Jacquelyn, primary, Chen, Longwen, primary, Doering, Karen A., primary, Burger, Kelli N., primary, Mahoney, Douglas W., primary, Sherman, Mark E., primary, Kisiel, John B., primary, and Samadder, N. Jewel, primary

Published
2023
Full Text
View/download PDF

22. Supplemental Figure 2 from Methylated DNA Markers for Sporadic Colorectal and Endometrial Cancer Are Strongly Associated with Lynch Syndrome Cancers

Author

Bramblet, Rachel M., primary, Bakkum-Gamez, Jamie N., primary, Slettedahl, Seth W., primary, Foote, Patrick H., primary, Taylor, William R., primary, Berger, Calise K., primary, Gysbers, Brianna J., primary, Arndt, Jacquelyn, primary, Chen, Longwen, primary, Doering, Karen A., primary, Burger, Kelli N., primary, Mahoney, Douglas W., primary, Sherman, Mark E., primary, Kisiel, John B., primary, and Samadder, N. Jewel, primary

Published
2023
Full Text
View/download PDF

26. Methylated DNA Markers for Sporadic Colorectal and Endometrial Cancer Are Strongly Associated with Lynch Syndrome Cancers

Author

Bramblet, Rachel M., primary, Bakkum-Gamez, Jamie N., additional, Slettedahl, Seth W., additional, Foote, Patrick H., additional, Taylor, William R., additional, Berger, Calise K., additional, Gysbers, Brianna J., additional, Arndt, Jacquelyn, additional, Chen, Longwen, additional, Doering, Karen A., additional, Burger, Kelli N., additional, Mahoney, Douglas W., additional, Sherman, Mark E., additional, Kisiel, John B., additional, and Samadder, N. Jewel, additional

Published
2023
Full Text
View/download PDF

27. Abstract PO-039: Discovery and validation of methylated DNA markers of human papillomavirus associated oropharyngeal squamous cell carcinoma

Author

Gochanour, Benjamin R., primary, Routman, David M., additional, Bartemes, Kathleen R., additional, Taylor, William R., additional, Mahoney, Douglas W., additional, Graham, Rondell P., additional, Cao, Xiaoming, additional, Berger, Calise K., additional, Then, Sara S., additional, Doering, Karen A., additional, Burger, Kelli N., additional, Foote, Patrick H., additional, Kisiel, John B., additional, and Van Abel, Kathryn M., additional

Published
2023
Full Text
View/download PDF

30. Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility

Author

Marinelli, Lisa M., Kisiel, John B., Slettedahl, Seth W., Mahoney, Douglas W., Lemens, Maureen A., Shridhar, Vijayalakshmi, Taylor, William R., Staub, Julie K., Cao, Xiaoming, Foote, Patrick H., Burger, Kelli N., Berger, Calise K., O’Connell, Maria C., Doering, Karen A., Giakoumopoulos, Maria, Berg, Hannah, Volkmann, Carla, Solsrud, Adam, Allawi, Hatim T., Kaiser, Michael, Vaccaro, Abram M., Crawford, Catherine Albright, Moehlenkamp, Cynthia, Shea, Gracie, Deist, Melissa S., Schoolmeester, J. Kenneth, Kerr, Sarah E., Sherman, Mark E., and Bakkum-Gamez, Jamie N.

Subjects
Genetic Markers, Ovarian Neoplasms, Obstetrics and Gynecology, Nerve Tissue Proteins, Carcinoma, Ovarian Epithelial, DNA Methylation, Article, Oncology, Biomarkers, Tumor, CELF Proteins, Feasibility Studies, Humans, Female, Transaminases
Abstract

OBJECTIVE: Aberrant DNA methylation is an early event in carcinogenesis which could be leveraged to detect ovarian cancer (OC) in plasma. METHODS: DNA from frozen OC tissues, benign fallopian tube epithelium (FTE), and buffy coats from cancer-free women underwent reduced representation bisulfite sequencing (RRBS) to identify OC MDMs. Candidate MDM selection was based on receiver operating characteristic (ROC) discrimination, methylation fold change, and low background methylation among controls. Blinded biological validation was performed using methylated specific PCR on DNA extracted from independent OC and FTE FFPE tissues. MDMs were tested using Target Enrichment Long-probe Quantitative Amplified Signal (TELQAS) assays in pre-treatment plasma from women newly diagnosed with OC and population-sampled healthy women. A random forest modeling analysis was performed to generate predictive probability of disease; results were 500-fold in silico cross-validated. RESULTS: Thirty-three MDMs showed marked methylation fold changes (10 to >1000) across all OC subtypes vs FTE. Eleven MDMs (GPRIN1, CDO1, SRC, SIM2, AGRN, FAIM2, CELF2, RIPPLY3, GYPC, CAPN2, BCAT1) were tested on plasma from 91 women with OC (73 (80%) high-grade serous (HGS)) and 91 without OC; the cross-validated 11-MDM panel highly discriminated OC from controls (96% (95% CI, 89–99%) specificity; 79% (69–87%) sensitivity, and AUC 0.91 (0.86 – 0.96)). Among the 5 stage I/II HGS OCs included, all were correctly identified. CONCLUSIONS: Whole methylome sequencing, stringent filtering criteria, and biological validation yielded candidate MDMs for OC that performed with high sensitivity and specificity in plasma. Larger plasma-based OC MDM studies, including testing of pre-diagnostic specimens, are warranted.

Published
2022

31. Supplemental Figures 1-6 from New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice

Author

Kisiel, John B., primary, Raimondo, Massimo, primary, Taylor, William R., primary, Yab, Tracy C., primary, Mahoney, Douglas W., primary, Sun, Zhifu, primary, Middha, Sumit, primary, Baheti, Saurabh, primary, Zou, Hongzhi, primary, Smyrk, Thomas C., primary, Boardman, Lisa A., primary, Petersen, Gloria M., primary, and Ahlquist, David A., primary

Published
2023
Full Text
View/download PDF

32. Supplemental Figure 4 from Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence

Author

Xie, Hao, primary, Mahoney, Douglas W., primary, Foote, Patrick H., primary, Burger, Kelli N., primary, Doering, Karen A., primary, Taylor, William R., primary, Then, Sara S., primary, Cao, Xiaoming, primary, McGlinch, Maria, primary, Berger, Calise K., primary, Wu, Tsung-Teh, primary, Hubbard, Joleen M., primary, Allawi, Hatim T., primary, Kaiser, Michael W., primary, Lidgard, Graham P., primary, Ahlquist, David A., primary, and Kisiel, John B., primary

Published
2023
Full Text
View/download PDF

33. Supplemental Table 2 from New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice

Author

Kisiel, John B., primary, Raimondo, Massimo, primary, Taylor, William R., primary, Yab, Tracy C., primary, Mahoney, Douglas W., primary, Sun, Zhifu, primary, Middha, Sumit, primary, Baheti, Saurabh, primary, Zou, Hongzhi, primary, Smyrk, Thomas C., primary, Boardman, Lisa A., primary, Petersen, Gloria M., primary, and Ahlquist, David A., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Data from Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma

Author

Qin, Yi, primary, Wu, Chung W., primary, Taylor, William R., primary, Sawas, Tarek, primary, Burger, Kelli N., primary, Mahoney, Douglas W., primary, Sun, Zhifu, primary, Yab, Tracy C., primary, Lidgard, Graham P., primary, Allawi, Hatim T., primary, Buttar, Navtej S., primary, Smyrk, Thomas C., primary, Iyer, Prasad G., primary, Katzka, David A., primary, Ahlquist, David A., primary, and Kisiel, John B., primary

Published
2023
Full Text
View/download PDF

35. Supplemental Figure 3 from Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence

Author

Xie, Hao, primary, Mahoney, Douglas W., primary, Foote, Patrick H., primary, Burger, Kelli N., primary, Doering, Karen A., primary, Taylor, William R., primary, Then, Sara S., primary, Cao, Xiaoming, primary, McGlinch, Maria, primary, Berger, Calise K., primary, Wu, Tsung-Teh, primary, Hubbard, Joleen M., primary, Allawi, Hatim T., primary, Kaiser, Michael W., primary, Lidgard, Graham P., primary, Ahlquist, David A., primary, and Kisiel, John B., primary

Published
2023
Full Text
View/download PDF

36. Supplemental Figure 2 from Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence

Author

Xie, Hao, primary, Mahoney, Douglas W., primary, Foote, Patrick H., primary, Burger, Kelli N., primary, Doering, Karen A., primary, Taylor, William R., primary, Then, Sara S., primary, Cao, Xiaoming, primary, McGlinch, Maria, primary, Berger, Calise K., primary, Wu, Tsung-Teh, primary, Hubbard, Joleen M., primary, Allawi, Hatim T., primary, Kaiser, Michael W., primary, Lidgard, Graham P., primary, Ahlquist, David A., primary, and Kisiel, John B., primary

Published
2023
Full Text
View/download PDF

37. Supplemental Table 1 from New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice

Author

Kisiel, John B., primary, Raimondo, Massimo, primary, Taylor, William R., primary, Yab, Tracy C., primary, Mahoney, Douglas W., primary, Sun, Zhifu, primary, Middha, Sumit, primary, Baheti, Saurabh, primary, Zou, Hongzhi, primary, Smyrk, Thomas C., primary, Boardman, Lisa A., primary, Petersen, Gloria M., primary, and Ahlquist, David A., primary

Published
2023
Full Text
View/download PDF

38. Supplemental Table 1 from Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence

Author

Xie, Hao, primary, Mahoney, Douglas W., primary, Foote, Patrick H., primary, Burger, Kelli N., primary, Doering, Karen A., primary, Taylor, William R., primary, Then, Sara S., primary, Cao, Xiaoming, primary, McGlinch, Maria, primary, Berger, Calise K., primary, Wu, Tsung-Teh, primary, Hubbard, Joleen M., primary, Allawi, Hatim T., primary, Kaiser, Michael W., primary, Lidgard, Graham P., primary, Ahlquist, David A., primary, and Kisiel, John B., primary

Published
2023
Full Text
View/download PDF

39. Supplemental Table 2 from Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence

Author

Xie, Hao, primary, Mahoney, Douglas W., primary, Foote, Patrick H., primary, Burger, Kelli N., primary, Doering, Karen A., primary, Taylor, William R., primary, Then, Sara S., primary, Cao, Xiaoming, primary, McGlinch, Maria, primary, Berger, Calise K., primary, Wu, Tsung-Teh, primary, Hubbard, Joleen M., primary, Allawi, Hatim T., primary, Kaiser, Michael W., primary, Lidgard, Graham P., primary, Ahlquist, David A., primary, and Kisiel, John B., primary

Published
2023
Full Text
View/download PDF

40. Supplemental Figure 5 from Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence

Author

Xie, Hao, primary, Mahoney, Douglas W., primary, Foote, Patrick H., primary, Burger, Kelli N., primary, Doering, Karen A., primary, Taylor, William R., primary, Then, Sara S., primary, Cao, Xiaoming, primary, McGlinch, Maria, primary, Berger, Calise K., primary, Wu, Tsung-Teh, primary, Hubbard, Joleen M., primary, Allawi, Hatim T., primary, Kaiser, Michael W., primary, Lidgard, Graham P., primary, Ahlquist, David A., primary, and Kisiel, John B., primary

Published
2023
Full Text
View/download PDF

41. Figure S2 from High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9

Author

Majumder, Shounak, primary, Taylor, William R., primary, Foote, Patrick H., primary, Berger, Calise K., primary, Wu, Chung Wah, primary, Mahoney, Douglas W., primary, Bamlet, William R., primary, Burger, Kelli N., primary, Postier, Neil, primary, de la Fuente, Jaime, primary, Doering, Karen A., primary, Lidgard, Graham P., primary, Allawi, Hatim T., primary, Petersen, Gloria M., primary, Chari, Suresh T., primary, Ahlquist, David A., primary, and Kisiel, John B., primary

Published
2023
Full Text
View/download PDF

42. Supplemental Table 3 from Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence

Author

Xie, Hao, primary, Mahoney, Douglas W., primary, Foote, Patrick H., primary, Burger, Kelli N., primary, Doering, Karen A., primary, Taylor, William R., primary, Then, Sara S., primary, Cao, Xiaoming, primary, McGlinch, Maria, primary, Berger, Calise K., primary, Wu, Tsung-Teh, primary, Hubbard, Joleen M., primary, Allawi, Hatim T., primary, Kaiser, Michael W., primary, Lidgard, Graham P., primary, Ahlquist, David A., primary, and Kisiel, John B., primary

Published
2023
Full Text
View/download PDF

43. Supplemental Legends and Tables from Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma

Author

Anderson, Bradley W., primary, Suh, Yun-Suhk, primary, Choi, Boram, primary, Lee, Hyuk-Joon, primary, Yab, Tracy C., primary, Taylor, William R., primary, Dukek, Brian A., primary, Berger, Calise K., primary, Cao, Xiaoming, primary, Foote, Patrick H., primary, Devens, Mary E., primary, Boardman, Lisa A., primary, Kisiel, John B., primary, Mahoney, Douglas W., primary, Slettedahl, Seth W., primary, Allawi, Hatim T., primary, Lidgard, Graham P., primary, Smyrk, Thomas C., primary, Yang, Han-Kwang, primary, and Ahlquist, David A., primary

Published
2023
Full Text
View/download PDF

44. Supplementary Data from High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9

Author

Majumder, Shounak, primary, Taylor, William R., primary, Foote, Patrick H., primary, Berger, Calise K., primary, Wu, Chung Wah, primary, Mahoney, Douglas W., primary, Bamlet, William R., primary, Burger, Kelli N., primary, Postier, Neil, primary, de la Fuente, Jaime, primary, Doering, Karen A., primary, Lidgard, Graham P., primary, Allawi, Hatim T., primary, Petersen, Gloria M., primary, Chari, Suresh T., primary, Ahlquist, David A., primary, and Kisiel, John B., primary

Published
2023
Full Text
View/download PDF

45. Figure S1 from Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma

Author

Anderson, Bradley W., primary, Suh, Yun-Suhk, primary, Choi, Boram, primary, Lee, Hyuk-Joon, primary, Yab, Tracy C., primary, Taylor, William R., primary, Dukek, Brian A., primary, Berger, Calise K., primary, Cao, Xiaoming, primary, Foote, Patrick H., primary, Devens, Mary E., primary, Boardman, Lisa A., primary, Kisiel, John B., primary, Mahoney, Douglas W., primary, Slettedahl, Seth W., primary, Allawi, Hatim T., primary, Lidgard, Graham P., primary, Smyrk, Thomas C., primary, Yang, Han-Kwang, primary, and Ahlquist, David A., primary

Published
2023
Full Text
View/download PDF

46. Supplemental Methods from New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice

Author

Kisiel, John B., primary, Raimondo, Massimo, primary, Taylor, William R., primary, Yab, Tracy C., primary, Mahoney, Douglas W., primary, Sun, Zhifu, primary, Middha, Sumit, primary, Baheti, Saurabh, primary, Zou, Hongzhi, primary, Smyrk, Thomas C., primary, Boardman, Lisa A., primary, Petersen, Gloria M., primary, and Ahlquist, David A., primary

Published
2023
Full Text
View/download PDF

47. Supplemental Figure 1 from Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence

Author

Xie, Hao, primary, Mahoney, Douglas W., primary, Foote, Patrick H., primary, Burger, Kelli N., primary, Doering, Karen A., primary, Taylor, William R., primary, Then, Sara S., primary, Cao, Xiaoming, primary, McGlinch, Maria, primary, Berger, Calise K., primary, Wu, Tsung-Teh, primary, Hubbard, Joleen M., primary, Allawi, Hatim T., primary, Kaiser, Michael W., primary, Lidgard, Graham P., primary, Ahlquist, David A., primary, and Kisiel, John B., primary

Published
2023
Full Text
View/download PDF

48. Abstract P2-11-06: Plasma assay of methylated DNA markers (MDM) detects patients with metastatic breast cancer (MBC) compared to healthy controls and treated breast cancer patients with no evidence of disease

Author

Giridhar, Karthik V., primary, Couch, Fergus J., additional, Sinnwell, Jason P., additional, Slettedahl, Seth W., additional, Taylor, William R., additional, Mahoney, Douglas W., additional, Foote, Patrick H., additional, O’Connell, Maria C., additional, Robran, Mariah J., additional, Devens, Mary E., additional, Gonser, Anna M., additional, Larson, Nicole, additional, Doering, Karen A., additional, Burger, Kelli N., additional, Kaiser, Michael, additional, Allawi, Hatim, additional, Ruddy, Kathryn, additional, Olson, Janet, additional, and Kisiel, John B., additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results